Browsing by Publisher "TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICES"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    mRNA as a Therapeutics: Understanding mRNA Vaccines
    (TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICES) Oguz, F; Atmaca, H
    Vaccination is one of the important approaches in the prevention and control of diseases. Although the capacity to present antigens other than the disease-specific antigen in the traditional vaccine composition provides a potential benefit by increasing its protective efficacy, many components that are not needed for the related disease are also transferred. These components can reduce vaccine activity by lowering immunity against protective antigens. The reasons such as the low effectiveness of traditional vaccines and the high cost of production and time-consuming reasons show that it is necessary to develop a new vaccine method for our world, which is struggling with epidemics almost every year. Among nucleic acids, mRNA has many advantages, such as genomic integration, induction of anti-DNA autoantibodies, and immune tolerance induced by long-term antigen expression. mRNA vaccines have become a therapeutic target for reasons such as efficacy, safety, fast and non-expensive production. The fact that mRNA triggers both humoral and cellular immunity and goes only to the cytoplasm, not to the nucleus, makes it highly efficient. The mRNA must cross the lipid bilayer barrier and entry to the cytoplasm where it is translated into protein. There are two main ways of mRNA vaccine delivery for this: ex vivo loading of mRNA into dendritic cells (DCs) and direct injection of mRNA with or without a carrier. Studies continue to understand which delivery system is therapeutically more efficient. Preclinical and clinical trials showed that mRNA vaccines trigger a long-lasting and safe immune response.
  • No Thumbnail Available
    Item
    The role of PRP and adipose tissue-derived keratinocytes on burn wound healing in diabetic rats
    (TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICES) Mansoub, NH; Gürdal, M; Karadadas, E; Kabadayi, H; Vatansever, S; Ercan, G
    Introduction: Diabetic burn wounds and ulcers are significant complications of diabetic patients. The aim of this study was to investigate the use of platelet rich-plasma (PRP) and/or keratinocyte-like cells (KLCs) in diabetic thermal wound rat model and to evaluate EGF, FGF-2, TGF-beta 1, COL1 alpha 2, MCP-1 and VEGF-alpha as wound healing markers at the gene expression level. Methods: In this study, we used adipose tissue as the source of mesenchymal stem cells (MSCs) and differentiated MSCs into KLCs. KLCs were characterized and transferred to the burn areas on the dorsum of streptozotocin (STZ)-induced diabetic rats. We prepared PRP from rat blood and evaluated its effect alone or in combination with KLCs. On the 3rd, 7th, 10th and 14th days after the treatment, the wound areas were measured and biopsy samples were excised from the wound areas of the KLCs and/or PRP-treated and the untreated diabetic rats to analyze the gene expression levels of the wound healing markers by qPCR. Results: We observed that, wound contraction started earlier in the PRP and/or KLCs-treated groups in comparison to the control group. However, PRP and KLCs when applied in combination showed additive affect in the wound healing. In all groups treated with KLCs and/or PRP, the gene expression levels of evaluated growth factors and COL1a2 increased, while MCP-1 levels decreased when compared to the untreated diabetic rats. In addition, the most prominent difference in qPCR results belongs to the combined PRP and KLCs-treated group. Conclusion: We demonstrated that applying PRP and KLCs in combination has a greater potential for the treatment of diabetic burn wounds.